The speech and language disorder market is expected to grow from US$ 8.29 billion in 2022 to US$ 12.90 billion by 2030; it is anticipated to record a CAGR of 5.7% from 2022 to 2030.

Speech disorder is a condition in which the patient has a problem in forming or creating particular speech sounds required to communicate with others easily. Whereas, in language disorder, the person cannot understand the message or meaning the other person is trying to convey or has difficulty in expressing their thought properly. Speech and language disorders may sometimes occur due to behavioral or emotional disorders. Although these disorders are being addressed with various therapies in developed parts of the world, there is a significant shortage of healthcare professionals in underdeveloped or remote areas, which is hampering the speech and language disorder market growth.

Increasing Cases of Diseases Affecting Speech and Language Propels Speech and Language Disorder Market Growth.

Conditions such as stroke and neurodegenerative diseases can affect the motor function of the mouth, resulting in speech and language disorders in people. Parkinson's disease is the second-most common neurodegenerative disease after Alzheimer's disease, associated with cognitive impairment and motor control abnormalities. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. According to the Parkinson's Foundation data, in 2022, ~1 million people in the US are living with PD, and it is expected to reach 1.2 million by 2030. As per the same source, more than 10 million people are living with PD globally, and about 4% of the diagnosed cases are aged below 50. Dysarthria and aphasia are common speech disorders occurring in patients suffering from PD. According to the National Library of Medicine, about 90% of patients suffering from PD will develop dysarthria during the disease period.

As per the Burden of Stroke in Europe report conducted by King's College London for the Stroke Alliance for Europe, the incidence of stroke is likely to reach 35% in Spain, and its prevalence will rise to 31% by the end of 2035. According to IntechOpen, stroke is the fifth leading death cause in the US, and about one stroke occurs approximately every 40 seconds, and stroke-related death occurs roughly every 4 minutes. According to the study published by Elsevier, in China, 17.8 million cases of stroke, 3.4 million new strokes, and 2.3 million stroke-related deaths were reported in 2020. Thus, the speech and language disorder market size is likely to continue to surge due to the increasing prevalence of neurodegenerative diseases, such as PD and stroke.

The scope of the speech and language disorder market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America held the largest share of the global market in 2022 owing to increasing cases of neurodegenerative disorders, increasing use of application-based speech therapy, increasing prevalence of speech disorders such as disfluency, and the presence of key market players. As per the National Institute on Deafness and Other Communication Diseases, about 180,000 American are diagnosed with aphasia annually, and currently, ~1 million people are suffering from aphasia in the US. According to IntechOpen, stroke is the fifth leading death cause in the US, and about one stroke occurs approximately every 40 seconds, and stroke-related death occurs roughly every 4 minutes. According to the Parkinson's Foundation data, in 2022, ~1 million people in the US are living with Parkinson's disease, and it is expected to reach 1.2 million by 2030.

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA) are a few key primary and secondary sources referred to while preparing the report on the speech and language disorder market.